The frequency of CD163+ M2-like MØs has been reported to be notably increased in acute and chronic myeloid leukaemia [43,44], chronic lymphocytic leukaemia [45], multiple myeloma [46] and also adult ALL [47]. The gene discussed is CD163; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.